INTEGRA LIFESCIENCES HOLDINGS CORP Receivable for Recovery of Import Duties, Net
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had Receivable for Recovery of Import Duties, Net of $19.00 million as of 2026-03-31, per its 10-Q filed 2026-07-29.
Financial Statements › Notes
us-gaap:ReceivableForRecoveryOfImportDutiesNet · last filed 2026-07-29
- 2026-03-31: Receivable for Recovery of Import Duties, Net $19.00M; Receivable for Recovery of Import Duties, Net as first filed $18.70M.
| Period end | Receivable for Recovery of Import Duties, Net | Receivable for Recovery of Import Duties, Net as first filed |
|---|---|---|
| 2026-03-31 | $19.00M 10-Q · filed 2026-07-29 | $18.70M 10-Q · filed 2026-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |